Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to test the combination of decitabine, arsenic trioxide and ascorbic
acid in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia